Wei Y, Zheng H, Lockyer PP, Darbaniyan F, et al. MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2022 Sep 5:1-11. doi: 10.1080/10428194.2022.2116932.
PMID: 36059252